NOMAD Power Solutions, Inc.
NMADNASDAQHealthcareBiotechnology
Previous close
$4.30
+$0.09 · +2.14%
Aug 21, 4:00 PM ET
NMAD company overview
Regular session · ET · Market data may be delayed.
Company profile
Company websiteLixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Geordan G. Pursglove
- Listed since
- Nov 24, 2020
- Employees
- 3
Market position
Day range
Current $4.30
$4.24$4.37
52-week range
Current $4.30
$2.36$8.38
- Open
- $4.30
- Previous close
- $4.21
- Volume
- 166.12K
- 0.39× average
- Average volume
- 426.89K
- Average daily volume
- Market cap
- 53.15M USD
- Beta
- 1.3
- Market reference 1
- 50-day average
- $5.5132
- -22.01% below average
- 200-day average
- $4.3121
- -0.28% below average
NMAD news
NMAD peers
Continue in GoAI
Research NMADresearch.disclaimer